The aim of the present study was to evaluate the implementation of the 2003 Dutch guideline on the diagnosis and treatment of malignant pleural effusions, and the potential effect of the implementation on the clinical outcome of pleurodesis. All patients with malignant pleural effusion who had a pleural drain placed with the intention of performing pleurodesis were registered prospectively in four centres. Details of the procedure and fluid recurrence and survival data were noted. Patients with a proven malignancy (n = 100) were entered into the registration database. Diagnostic guideline recommendations were followed in 60-70% of the patients. Surprisingly, pleurodesis was performed in only 75% of the patients, mainly due to the presence o...
The first indwelling pleural catheter (IPC) received Federal Drug Administration approval in 1997, n...
OBJECTIVES:Recent observations indicate a potential survival benefit in patients with malignant pleu...
With no cure for malignant pleural effusion, efforts are focused on symptomatic management. Historic...
Contains fulltext : 71473.pdf (publisher's version ) (Closed access)The aim of the...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
OBJECTIVES: Malignant pleural effusion (MPE) commonly complicates advanced malignancy and their exac...
Malignant pleural effusion (MPE) affects more than 1 million people globally. There is a dearth of e...
Introduction Malignant pleural effusions (MPEs) can complicate most cancers, causing dyspnoea and im...
BACKGROUND: Pleurodesis is important in the management of malignant pleural effusions, but no consen...
Objectives: Pleurodesis is an important management option to palliate breathlessness in patients wit...
Introduction Malignant pleural effusion (MPE) is common and currently in UK there are an estimated 5...
Malignant pleural effusion (MPE) is common in clinical practice, and despite the existence of studie...
BACKGROUND: Approximately half of all patients with metastatic cancer develop a malignant pleural...
Background: This Guideline, a collaborative effort from the American Thoracic Society, Society of Th...
Malignant pleural effusion (MPE) occurs in 15% of all cancer patients and usually portends poor prog...
The first indwelling pleural catheter (IPC) received Federal Drug Administration approval in 1997, n...
OBJECTIVES:Recent observations indicate a potential survival benefit in patients with malignant pleu...
With no cure for malignant pleural effusion, efforts are focused on symptomatic management. Historic...
Contains fulltext : 71473.pdf (publisher's version ) (Closed access)The aim of the...
PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method t...
OBJECTIVES: Malignant pleural effusion (MPE) commonly complicates advanced malignancy and their exac...
Malignant pleural effusion (MPE) affects more than 1 million people globally. There is a dearth of e...
Introduction Malignant pleural effusions (MPEs) can complicate most cancers, causing dyspnoea and im...
BACKGROUND: Pleurodesis is important in the management of malignant pleural effusions, but no consen...
Objectives: Pleurodesis is an important management option to palliate breathlessness in patients wit...
Introduction Malignant pleural effusion (MPE) is common and currently in UK there are an estimated 5...
Malignant pleural effusion (MPE) is common in clinical practice, and despite the existence of studie...
BACKGROUND: Approximately half of all patients with metastatic cancer develop a malignant pleural...
Background: This Guideline, a collaborative effort from the American Thoracic Society, Society of Th...
Malignant pleural effusion (MPE) occurs in 15% of all cancer patients and usually portends poor prog...
The first indwelling pleural catheter (IPC) received Federal Drug Administration approval in 1997, n...
OBJECTIVES:Recent observations indicate a potential survival benefit in patients with malignant pleu...
With no cure for malignant pleural effusion, efforts are focused on symptomatic management. Historic...